Jeffrey M Saland

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi Dyslipidemia in children with chronic kidney disease
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, New York, New York 10029, USA
    Kidney Int 78:1154-63. 2010
  2. ncbi Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Clin J Am Soc Nephrol 4:201-6. 2009
  3. ncbi Update on the metabolic syndrome in children
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Curr Opin Pediatr 19:183-91. 2007
  4. ncbi Lipoprotein metabolism in chronic renal insufficiency
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L Levy Place, P O Box 1664, New York, NY 10029, USA
    Pediatr Nephrol 22:1095-112. 2007
  5. ncbi Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation
    J M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, New York, USA
    Am J Transplant 6:1948-52. 2006
  6. ncbi Osseous complications of pediatric transplantation
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
    Pediatr Transplant 8:400-15. 2004
  7. ncbi Liver-kidney transplantation to cure atypical hemolytic uremic syndrome
    Jeffrey M Saland
    Recanati Miller, Mount Sinai Medical Center, New York, New York, USA
    J Am Soc Nephrol 20:940-9. 2009
  8. ncbi Postrenal biopsy AVM leading to severe hypertension and dilated cardiomyopathy
    Nao Sasaki
    Mount Sinai Medical Center, Division of Pediatric Cardiology, One Gustave L Levy Place, New York, NY 10029, USA
    Pediatr Nephrol 24:2459-62. 2009
  9. ncbi Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, New York, New York 10029 6574, USA
    Curr Opin Pediatr 14:197-204. 2002
  10. ncbi Effective removal of methotrexate by high-flux hemodialysis
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L. Levy Place Box 1664, NY 10029-6574, USA
    Pediatr Nephrol 17:825-9. 2002

Research Grants

  1. Dyslipidemia in Chronic Kidney Disease
    Jeffrey Saland; Fiscal Year: 2007

Detail Information

Publications10

  1. ncbi Dyslipidemia in children with chronic kidney disease
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, New York, New York 10029, USA
    Kidney Int 78:1154-63. 2010
    ..Hence, among children with moderate chronic kidney disease, dyslipidemia is common and is associated with lower GFR, nephrotic proteinuria, and non-renal factors including age and obesity...
  2. ncbi Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Clin J Am Soc Nephrol 4:201-6. 2009
    ..A male infant with a family history of thrombotic microangiopathy developed atypical hemolytic uremic syndrome (aHUS)...
  3. ncbi Update on the metabolic syndrome in children
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, New York, NY 10029, USA
    Curr Opin Pediatr 19:183-91. 2007
    ..Provides an update on the metabolic syndrome in childhood...
  4. ncbi Lipoprotein metabolism in chronic renal insufficiency
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L Levy Place, P O Box 1664, New York, NY 10029, USA
    Pediatr Nephrol 22:1095-112. 2007
    ..Therefore, it is not possible at this time to endorse general recommendations for the use of any agent to treat dyslipidemia in children with chronic kidney disease...
  5. ncbi Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation
    J M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, New York, USA
    Am J Transplant 6:1948-52. 2006
    ..This report suggests that despite setbacks in previous experience, combined liver-kidney transplantation offers the prospect of a favorable long-term outcome for patients with HUS associated with complement factor H mutations...
  6. ncbi Osseous complications of pediatric transplantation
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
    Pediatr Transplant 8:400-15. 2004
    ..Careful research is required to determine the role of bisphosphonate therapy in pediatric transplantation...
  7. ncbi Liver-kidney transplantation to cure atypical hemolytic uremic syndrome
    Jeffrey M Saland
    Recanati Miller, Mount Sinai Medical Center, New York, New York, USA
    J Am Soc Nephrol 20:940-9. 2009
    ....
  8. ncbi Postrenal biopsy AVM leading to severe hypertension and dilated cardiomyopathy
    Nao Sasaki
    Mount Sinai Medical Center, Division of Pediatric Cardiology, One Gustave L Levy Place, New York, NY 10029, USA
    Pediatr Nephrol 24:2459-62. 2009
    ..The AVF was treated by transcatheter embolization using an Amplatzer vascular plug. Her blood pressure normalized after embolization, and her cardiac function normalized over the following 4 months...
  9. ncbi Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai Medical Center, New York, New York 10029 6574, USA
    Curr Opin Pediatr 14:197-204. 2002
    ..Prospective investigations are required to guide clinical management...
  10. ncbi Effective removal of methotrexate by high-flux hemodialysis
    Jeffrey M Saland
    Department of Pediatrics, The Mount Sinai School of Medicine, One Gustave L. Levy Place Box 1664, NY 10029-6574, USA
    Pediatr Nephrol 17:825-9. 2002
    ..Therapy is indicated in cases where compassionate use of CPDG(2) may not be available, or while awaiting its delivery...

Research Grants2

  1. Dyslipidemia in Chronic Kidney Disease
    Jeffrey Saland; Fiscal Year: 2007
    ..benefit from the combined excellence of two General Clinical Research Centers operating in the dynamic academic environments of Mount Sinai, Columbia University, and an active New York lipid and vascular disease research community ..